EUVIMEDEUVIMED entdecken
Open Access · CC BY 3.0

Liposomal Tumor Targeting in Drug Delivery Utilizing MMP-2- and MMP-9-Binding Ligands

Oula Penate Medina, Merja Haikola, Marja Tahtinen, Ilkka Simpura, Sami Kaukinen, Heli Valtanen, Ying Zhu, Sari Kuosmanen, Wei Cao, Justus Reunanen, Tuula Nurminen, Per E J Saris und 4 weitere

Journal of Drug Delivery · 2011

DOI: 10.1155/2011/160515 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Drug Delivery, 2011. Verfasst von Oula Penate Medina und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Sloan Kettering Institute for Cancer Research, 1275 York Ave., New York, NY 10065, USA. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Nanotechnology offers an alternative to conventional treatment options by enabling different drug delivery and controlled-release delivery strategies. Liposomes being especially biodegradable and in most cases essentially nontoxic offer a versatile platform for several different delivery approaches that can potentially enhance the delivery and targeting of therapies to tumors. Liposomes penetrate tumors spontaneously as a result of fenestrated blood vessels within tumors, leading to known enhanced permeability and subsequent drug retention effects. In addition, liposomes can be used to carry radioactive moieties, such as radiotracers, which can be bound at multiple locations within liposomes, making them attractive carriers for molecular imaging applications. Phage display is a technique that can deliver various high-affinity and selectivity peptides to different targets. In this study, gelatinase-binding peptides, found by phage display, were attached to liposomes by covalent peptide-PEG-PE anchor creating a targeted drug delivery vehicle. Gelatinases as extracellular targets for tumor targeting offer a viable alternative for tumor targeting. Our findings show that targeted drug delivery is more efficient than non-targeted drug delivery.

Autor:innen und Institutionen

  • Department of Radiology, Sloan Kettering Institute for Cancer Research, 1275 York Ave., New York, NY 10065, USA.

Zitieren

APA

Penate Medina, O., Haikola, M., Tahtinen, M., Simpura, I., Kaukinen, S., Valtanen, H., Zhu, Y., Kuosmanen, S., Cao, W., Reunanen, J., Nurminen, T., Saris, P. E., Smith-Jones, P., Bradbury, M., Larson, S., & Kairemo, K. (2011). Liposomal Tumor Targeting in Drug Delivery Utilizing MMP-2- and MMP-9-Binding Ligands. Journal of Drug Delivery. https://doi.org/10.1155/2011/160515

Vancouver

Penate Medina O, Haikola M, Tahtinen M, Simpura I, Kaukinen S, Valtanen H, et al. Liposomal Tumor Targeting in Drug Delivery Utilizing MMP-2- and MMP-9-Binding Ligands. Journal of Drug Delivery. 2011. doi:10.1155/2011/160515

BibTeX
@article{PenateMedina2011,
  author = {Penate Medina, Oula and Haikola, Merja and Tahtinen, Marja and Simpura, Ilkka and Kaukinen, Sami and Valtanen, Heli and Zhu, Ying and Kuosmanen, Sari and Cao, Wei and Reunanen, Justus and Nurminen, Tuula and Saris, Per E J and Smith-Jones, Peter and Bradbury, Michelle and Larson, Steven and Kairemo, Kalevi},
  title = {Liposomal Tumor Targeting in Drug Delivery Utilizing MMP-2- and MMP-9-Binding Ligands},
  journal = {Journal of Drug Delivery},
  year = {2011},
  doi = {10.1155/2011/160515}
}
Kostenlos starten →